Despite the depletion of CD3+ T cells, CD19+ B cells, and NK1.1+ NK cells, the 3C-LNP treatment group still exhibited pronounced inhibition of tumor growth relative to the PBS control group. The gene discussed is CD19; the disease is neoplasm.